Business Issue
As Pharmacy OneSource positioned itself for an exit, Andy Strunk recognized that shifts in health system purchasing dynamics created new challenges and opportunities.
Traditionally, pharmacy departments had autonomy in selecting SaaS solutions, but hospital leadership began consolidating purchasing decisions, requiring software solutions to serve both Pharmacy and Infection Prevention teams.
To maintain competitiveness and expand market potential, Pharmacy OneSource needed to evolve its product strategy to address these broader enterprise needs while simultaneously increasing enterprise valuation ahead of a planned acquisition.
Action Taken
Mr. Strunk led market and field research efforts to identify shifting customer requirements and develop a strategic product extension that strengthened the company’s position in enterprise-wide health system purchasing:
- Market Expansion Through Product Innovation: Conceived and developed an extension to Sentri7, a cloud-based analytics tool that enabled Infection Prevention teams to manage patient cohorting, NHSN reporting, and outbreak tracking, addressing a critical gap in hospital-wide infection control.
- Strategic Deal-Making: This innovation played a key role in securing the largest deal in company history, a high-value contract with a Fortune 500 acute care hospital operator, expanding Sentri7’s footprint across a major health system.
- Enterprise Value Growth: By leveraging product management and innovation expertise, the new offering increased recurring revenue streams, strengthening the company’s market positioning and financial profile in preparation for acquisition.
When Pharmacy OneSource was acquired by Wolters Kluwer, Andy’s impact was undeniable—he was retained and elevated to lead their Corporate Innovation Lab, where he shaped the future of digital health solutions within a global organization.
One of Andy’s most impressive accomplishments was championing an early-stage sepsis detection solution and carrying it forward through to launch. This was no small feat—it required deep expertise in product management, rigorous marketing research, and high-level executive engagement. His ability to synthesize complex challenges into clear, actionable strategies proved instrumental in delivering a solution that saved lives and strengthened Wolters Kluwer’s leadership in clinical decision support.
If your organization is tackling a high-stakes initiative—whether it’s launching a new product, navigating a complex M&A integration, or pioneering market-shifting innovation—Andy is the partner you need. His ability to bridge vision and execution is unmatched, and I highly recommend reaching out to him to explore how he can bring the same level of success to your business.
Keith Streckenbach
Serial Entrepreneur and CEO of Pharmacy Stars
Impact Delivered
Pharmacy OneSource successfully executed a strategy that increased revenue, expanded market opportunities, and directly contributed to a higher company valuation:
- Closed the largest deal in company history, securing a high-profile contract that expanded Sentri7’s adoption across a national hospital network.
- Expanded total addressable market (TAM) by meeting the needs of both Pharmacy and Infection Prevention teams, increasing strategic relevance within health systems.
- Boosted enterprise valuation ahead of acquisition, driving a more profitable exit for employees and shareholders.
By aligning product innovation with evolving market needs, Pharmacy OneSource strengthened its competitive position, enhanced recurring revenue potential, and maximized shareholder value, ultimately contributing to a successful and high-value company exit.
